Skip to main content

Table 1 Characteristics of patients with and without NAFLD

From: Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study

 

w/o NAFLD (n = 2241)

w/ NAFLD (n = 2084)

P value

Sex

  

0.003

 Male

1297 (57.9)

1114 (53.4)

 

 Female

944 (42.1)

970 (46.6)

 

Age (years)

61.86 ± 11.57

57.50 ± 12.07

< 0.001

Diabetes duration (years)

11.38 ± 7.27

9.27 ± 6.58

0.001

BMI (kg/m2)

23.67 ± 3.18

26.63 ± 3.34

0.012

Waist circumference (cm)

 Male

87.92 ± 9.17

97.01 ± 9.37

< 0.001

 Female

86.10 ± 10.32

93.57 ± 9.85

< 0.001

SBP (mmHg)

133.02 ± 17.53

133.29 ± 16.55

0.005

DBP (mmHg)

78.65 ± 9.48

81.24 ± 9.33

0.001

ALT (IU/L)

20.39 ± 24.11

29.36 ± 23.40

< 0.001

AST (IU/L)

20.39 ± 24.11

23.50 ± 15.49

< 0.001

Gamma-GT (IU/L)

30.24 ± 39.20

40.75 ± 40.73

< 0.001

TC (mmol/L)

4.60 ± 1.10

4.85 ± 1.15

< 0.001

TG (mmol/L)

1.29 ± 1.07

2.23 ± 1.99

< 0.001

LDL-C (mmol/L)

2.76 ± 0.87

2.84 ± 0.86

0.003

GA (%)

22.75 ± 7.48

21.14 ± 6.02

< 0.001

HbA1c (%)

8.46 ± 2.18

8.65 ± 1.87

0.003

Gallstone disease

475 (21.2)

496 (23.8)

0.15

Cholecystectomy

209 (9.3)

329 (15.8)

< 0.001

Gallstones

266 (11.9)

167 (8)

< 0.001

  1. Data are presented as the mean ± SD. Binary variables are presented as the number (percentage)
  2. NAFLD, nonalcoholic fatty liver disease; w/o, without; w/, with; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Gamma-GT, gamma-glutamyl transpeptidase; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; GA, glycosylated albumin; HbA1c, glycosylated hemoglobin